Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?
Kyverna Therapeutics Ownership Summary
Kyverna Therapeutics is owned by 52.17% institutional investors, 11.88% insiders, and 35.96% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 10.47% of KYTX shares.
KYTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kyverna Therapeutics | 52.17% | 11.88% | 35.96% |
| Sector | Healthcare Stocks | 42.52% | 10.82% | 46.66% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 10.47% | $27.14M |
| Gilead sciences | 4.13M | 9.55% | $24.76M |
| Bain capital life sciences investors | 3.37M | 7.79% | $20.21M |
| Price t rowe associates inc /md/ | 1.51M | 3.50% | $9.07M |
| Vanguard group | 1.32M | 3.06% | $7.94M |
| Insight group | 989.05K | 2.29% | $5.93M |
| Franklin resources | 677.59K | 1.57% | $4.07M |
| Mbb public markets i | 614.48K | 1.42% | $3.69M |
| Catalio capital management, lp | 586.91K | 1.36% | $3.52M |
| Blackrock funding, inc. /de | 482.05K | 1.12% | $2.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 92.41% | $27.14M |
| Peapod lane capital | 318.76K | 1.71% | $1.91M |
| Gilead sciences | 4.13M | 1.38% | $24.76M |
| Bain capital life sciences investors | 3.37M | 1.34% | $20.21M |
| Catalio capital management, lp | 586.91K | 0.65% | $3.52M |
| Caxton | 22.98K | 0.60% | $137.89K |
| Mbb public markets i | 614.48K | 0.49% | $3.69M |
| Kera capital partners | 421.92K | 0.38% | $2.53M |
| Insight group | 989.05K | 0.37% | $5.93M |
| Phoenix wealth advisors | 10.50K | 0.02% | $63.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodline partners lp | 252.21K | 0.01% | 252.21K |
| Bridgeway capital management | 174.90K | 0.02% | 112.00K |
| Jane street group | 198.85K | 0.00% | 111.08K |
| Ubs group | 157.42K | 0.00% | 59.26K |
| Renaissance | 164.61K | 0.00% | 42.20K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Novo | - | - | -1.85M |
| Integral health asset management | - | - | -350.00K |
| Price t rowe associates inc /md/ | 1.51M | 0.00% | -318.30K |
| Rock springs capital management lp | - | - | -178.96K |
| Superstring capital management lp | - | - | -142.54K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Woodline partners lp | 252.21K | 0.01% | 252.21K | $1.51M |
| American century companies | 32.20K | 0.00% | 32.20K | $193.23K |
| Jefferies financial group | 16.30K | 0.00% | 16.30K | $97.80M |
| Trexquant investment lp | 15.11K | 0.00% | 15.11K | $90.65K |
| Ameriprise financial | 12.88K | - | 12.88K | $77.29M |
Sold Out
| Holder | Change |
|---|---|
| Rothschild investment | -50.00 |
| Jones financial companies lllp | -81.00 |
| Sterling capital management | -186.00 |
| Raymond james financial | -189.00 |
| True wealth design | -220.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 76 | 1.33% | 22,548,873 | 0.47% | 52 | 1.94% | 30 | -26.83% | 26 | 8.33% |
| Jun 30, 2025 | 79 | -10.23% | 23,198,522 | -10.03% | 53 | 1.51% | 44 | 4.76% | 24 | -4.00% |
| Mar 31, 2025 | 88 | -1.12% | 25,809,724 | -9.40% | 59 | 1.37% | 41 | -26.79% | 25 | 92.31% |
| Dec 31, 2024 | 90 | -4.26% | 28,867,980 | 2.72% | 66 | 1.58% | 57 | 11.76% | 13 | -38.10% |
| Sep 30, 2024 | 94 | 4.44% | 28,104,372 | -12.02% | 65 | 1.19% | 51 | -19.05% | 21 | 90.91% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2024 | GILEAD SCIENCES, INC. | - | Buy | $20.02M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | 1 | - |
KYTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools